Mohammed H, Mohamed H, Mohamed N, Sharma R, Sagar J
Cancers (Basel). 2025; 17(4).
PMID: 40002183
PMC: 11853685.
DOI: 10.3390/cancers17040588.
Brennan K, Farooq A, Mckechnie T, Wiseman V, Kong W, Bankhead C
Colorectal Dis. 2025; 27(1):e17276.
PMID: 39797387
PMC: 11724163.
DOI: 10.1111/codi.17276.
Sun A, Fan S, Choi S
Cancer Med. 2025; 14(1):e70523.
PMID: 39764760
PMC: 11705464.
DOI: 10.1002/cam4.70523.
Ji X, Xu S, Li X, Xu J, Han R, Guo Y
World J Gastrointest Oncol. 2024; 16(12):4597-4613.
PMID: 39678810
PMC: 11577370.
DOI: 10.4251/wjgo.v16.i12.4597.
Singhi A, Lee T, Ahn H, Shin H, Choi M, Jo M
Tech Coloproctol. 2024; 29(1):15.
PMID: 39661208
DOI: 10.1007/s10151-024-03046-7.
Resection of Early Colorectal Neoplasms Using Endoscopic Submucosal Dissection: A Retrospective Multicenter Cohort Study.
Winter K, Kasprzyk P, Nowicka Z, Noriko S, Herreros-de-Tejada A, Spychalski M
J Clin Med. 2024; 13(22).
PMID: 39598133
PMC: 11595630.
DOI: 10.3390/jcm13226989.
Endoscopic Resection of Neoplasia in the Lower GI Tract: A Clinical Algorithm.
OSullivan T, Bourke M
Visc Med. 2024; 40(4):217-227.
PMID: 39157731
PMC: 11326768.
DOI: 10.1159/000539219.
Clinical outcomes of colorectal neoplasm with positive resection margin after endoscopic submucosal dissection.
Oh H, Kim J, Lim J, Lim C, Seo Y, You G
Sci Rep. 2024; 14(1):12353.
PMID: 38811758
PMC: 11136969.
DOI: 10.1038/s41598-024-63129-1.
Histopronostic factors in superficial colorectal adenocarcinomas treated by endoscopy: reproducibility and impact of immunohistochemistry and digital pathology.
Pontarollo G, Bonjour M, Walter T, Pioche M, Lavrut P, Rabeyrin M
Virchows Arch. 2024; 485(2):233-244.
PMID: 38273213
PMC: 11329611.
DOI: 10.1007/s00428-023-03722-3.
Potential Molecular Markers Related to Lymph Node Metastasis and Stalk Resection Margins in Pedunculated T1 Colorectal Cancers Using Digital Spatial Profiling: A Pilot Study with a Small Case Series.
Kwon M, Park H, Lim H, Son I, Kim M, Kim N
Int J Mol Sci. 2024; 25(2).
PMID: 38256174
PMC: 10816845.
DOI: 10.3390/ijms25021103.
Are the width, length, depth, and area of submucosal invasion predictive of lymph node metastasis in pT1 colorectal cancer?.
Maynovskaia O, Rybakov E, Chernyshov S, Khomyakov E, Achkasov S
Ann Coloproctol. 2023; 39(6):484-492.
PMID: 38146608
PMC: 10781608.
DOI: 10.3393/ac.2023.00087.0012.
A Retrospective Multicenter Study of Risk Factors, Stratification, and Prognosis of Lymph Node Metastasis in T1 and T2 Colorectal Cancer.
Kim E, Son I, Kim B, Park J, Kang B, Kim J
J Clin Med. 2023; 12(24).
PMID: 38137813
PMC: 10743749.
DOI: 10.3390/jcm12247744.
Lymph Node Molecular Analysis with OSNA Enables the Identification of pT1 CRC Patients at Risk of Recurrence: A Multicentre Study.
de Gordoa K, Rodrigo-Calvo M, Archilla I, Lopez-Prades S, Diaz A, Tarragona J
Cancers (Basel). 2023; 15(22).
PMID: 38001742
PMC: 10670609.
DOI: 10.3390/cancers15225481.
Differences in treatment of stage I colorectal cancers: a population-based study of colorectal cancers detected within and outside of a screening program.
Toes-Zoutendijk E, Breekveldt E, van der Schee L, Nagtegaal I, Elferink M, Lansdorp-Vogelaar I
Endoscopy. 2023; 56(1):5-13.
PMID: 37935373
PMC: 10736105.
DOI: 10.1055/a-2173-5989.
Endoscopic Submucosal Dissection of Superficial Colorectal Neoplasms at "Challenging Sites" Using a Double-Balloon Endoluminal Interventional Platform: A Single-Center Study.
Andrisani G, Di Matteo F
Diagnostics (Basel). 2023; 13(19).
PMID: 37835897
PMC: 10572117.
DOI: 10.3390/diagnostics13193154.
Predicting prognosis through the discovery of specific biomarkers according to colorectal cancer lymph node metastasis.
Park S, Kang J, Kim H, Yoon S, Kim B, Lim C
Am J Cancer Res. 2023; 13(7):3221-3233.
PMID: 37559990
PMC: 10408476.
Local versus radical surgery for early rectal cancer with or without neoadjuvant or adjuvant therapy.
Motamedi M, Mak N, Brown C, Raval M, Karimuddin A, Giustini D
Cochrane Database Syst Rev. 2023; 6:CD002198.
PMID: 37310167
PMC: 10264720.
DOI: 10.1002/14651858.CD002198.pub3.
Diagnostic and Therapeutic Management of Early Colorectal Cancer.
Knoblauch M, Kuhn F, von Ehrlich-Treuenstatt V, Werner J, Renz B
Visc Med. 2023; 39(1):10-16.
PMID: 37265550
PMC: 10230821.
DOI: 10.1159/000526633.
Relationship between Tumor Budding and Partial Epithelial-Mesenchymal Transition in Head and Neck Cancer.
Okuyama K, Suzuki K, Yanamoto S
Cancers (Basel). 2023; 15(4).
PMID: 36831453
PMC: 9953904.
DOI: 10.3390/cancers15041111.
Tumor-infiltrating T cells as a risk factor for lymph node metastasis in patients with submucosal colorectal cancer.
Kitakaze M, Fujino S, Miyoshi N, Sekido Y, Hata T, Ogino T
Sci Rep. 2023; 13(1):2077.
PMID: 36746991
PMC: 9902519.
DOI: 10.1038/s41598-023-29260-1.